In April 2025, the Trump administration reversed a Biden-era decision and announced that Medicare would no longer cover GLP-1 medications specifically for weight loss
Granhall C, Donsmark M, Blicher TM, Golor G, Sndergaard FL, Thomsen M, Bkdal TA
[10] Ciebiera, M., ukaszuk, K., Mczekalski, B., Ciebiera, M., Wojtya, C., Sabuszewska-Jwiak, A., & Jakiel, G
Regardless of formulary positioning, ensuring adequate training of health plan staff and/or oversight of your PBM if delegated is in place regarding the handling of Wegovy cases will certify appropriate decision-making and appropriately worded member letters
This endogenous peptide plays a crucial role in glucose homeostasis and metabolic regulation
Synthesized via SPPS and HPLC-purified, it ensures high analytical purity for controlled biochemical research and assay applications